DNA overexpression may signal cancer
Certain DNA sequences were never suspected of having a role in cancer—until now. Cells in the most common type of solid tumor have now been found to feature massive overexpression of these sequences.
Certain DNA sequences were never suspected of having a role in cancer—until now. Cells in the most common type of solid tumor have now been found to feature massive overexpression of these sequences.
People with pulmonary tuberculosis appear to be at heightened risk of developing lung cancer, according to the results of a large, long-term study.
Adding iniparib to gemcitabine and carboplatin significantly increased clinical benefit and survival—but not toxic effects—in women with metastatic triple-negative breast cancer.
The easy-to-detect tumor suppressor PML may help distinguish benign tumors from cancers, now that researchers have found benign cells produce the PML molecule and display abundant PML bodies.
A naturally occurring protein inhibits tumor growth and metastasis into secondary organs and has the potential to be developed into an anticancer drug, scientists have found.
A major transformation is under way for the National Cancer Institute’s Clinical Trials Cooperative Group Program, which conducts many of the nationwide trials for new cancer therapies.
An important gene deletion appears to occur in as many as 1 of every 4 cases of glioblastoma—the most common adult brain cancer—scientists have found.
The failure of discoveries involving cancer biomarkers to fuel clinical success may stem from many problems, according to a study published in the Journal of the National Cancer Institute (2010 Aug 12. [Epub ahead of print]).
Doctors may be able to treat cancer effectively by combining arsenic with other therapies, according to a study published in the Proceedings of the National Academy of Sciences (2010 Jul 12. [Epub ahead of print]).
Oncology nurses involved in clinical trials must understand the basics of cancer research and their practice’s studies.